This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Referral criteria from primary care (polymyalgia rheumatica)

Authoring team

This condition is normally managed satisfactorily in primary care.

Earlyspecialist referral is recommended for:

  • patients with atypical features or features that increase likelihood of a non-PMR diagnosis:
    • younger patient < 60 years
    • chronic onset
    • lack of shoulder involvement
    • lack of inflammatory stiffness
    • ‘Red flag’ features: prominent systemic features, weight loss, night pain, neurological signs
    • peripheral arthritis or other features of CTD/ muscle disease
    • normal or very high ESR/CRP
  • or treatment dilemmas such as:
    • incomplete or non-response to corticosteroids
    • ill-sustained response
    • unable to reduce corticosteroid dose
    • need for prolonged corticosteroid therapy (longer than two years)
    • contra-indications to corticosteroid therapy

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.